BNB Plus Corp.
NASDAQ · us_market
No AI summary generated yet for this ticker.
BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.
BNB Plus Corp. (NASDAQ: $BNBX) is adding new capital to its crypto-treasury overhaul as the Nasdaq-listed company t...
BNB Plus Corp. (NASDAQ: $BNBX) is adding new capital to its crypto-treasury overhaul as the Nasdaq-listed company t...
Proceeds from the Financing will be used to bolster the Company's digital asset treasury and will provide working capital in support of a comprehensive strategic review. With the anticipated proceeds, the Company expects
BNB Plus (NASDAQ:BNBX) reported quarterly losses of $(0.68) per share. This is a 99.7 percent increase over losses of $(229.59) per share from the same period last year. The company reported $1.024 million in sales this
STONY BROOK, N.Y. — STONY BROOK, N.Y. — BNB Plus Corp. on Friday reported a loss of $6.7 million in its fiscal second quarter. On a per-share basis, the Stony Brook, New York-based company...
Major M&A deals this week include Eli Lilly buys Kelonia for $7 billion, Honeywell sells PSS to Brady Corp., KSL buys Invited Clubs.
BNB Plus Corp. , today announced that its biopharmaceutical subsidiary, LineaRx, Inc. , has successfully completed production of its largest order in LineaRx history.The $1.2 million order,...
In today's session, these stocks are experiencing unusual volume.
Company Treasury Exceeds $12 Million with Recently Implemented Active Yield Generation StrategyProvides Nasdaq Listing Status UpdateBNB Plus Corp. (NASDAQ:BNBX) ("BNB Plus" or the "Company"), a Nasdaq-listed digital
Company Treasury Exceeds $12 Million with Recently Implemented Active Yield Generation StrategyProvides Nasdaq Listing Status Update...
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
BNB Plus Corp. (Nasdaq: BNBX) ("BNBX" or the "Company"), announced today that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has been granted a European patent by the European Patent Office (EPO) related to
BNB Plus (NASDAQ:BNBX) reported quarterly losses of $(2.08) per share. This is a 99.5 percent increase over losses of $(420.00) per share from the same period last year. The company reported $565.394 thousand in sales
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-05-15 | — | — | — |
| 2025-08-14 | -37.50 | -33.42 | +10.88% |
| 2025-05-15 | -45.00 | -230.89 | -413.08% |
| 2025-02-13 | -247.50 | -421.20 | -70.18% |
| 2024-12-17 | -262.50 | -230.25 | +12.29% |
| 2024-08-08 | -262.50 | -612.82 | -133.46% |
| 2024-05-10 | -3300.00 | -3755.55 | -13.80% |
| 2024-02-08 | -4650.00 | -4135.50 | +11.06% |
| 2023-12-07 | -3975.00 | -4572.00 | -15.02% |
| 2023-08-10 | -3600.00 | -3279.00 | +8.92% |
| 2023-05-11 | -3000.00 | -3093.90 | -3.13% |
| 2023-02-09 | -4350.00 | -1395.00 | +67.93% |
| 2022-12-14 | -3525.00 | -5536.50 | -57.06% |
| 2022-08-11 | -5325.00 | -4813.50 | +9.61% |
| 2022-05-12 | -5000.00 | -4200.00 | +16.00% |
| 2022-02-10 | -2775.00 | -9450.00 | -240.54% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| BNBX | -14.00% | -30.65% | -65.04% | -91.57% |
| XLF | -0.65% | +0.72% | -5.82% | +1.22% |
| Alpha (stock − sector) | -13.35% | -31.37% | -59.22% | -92.79% |